Mutations in BRCA1 and BRCA2, tumor suppressor genes significantly increase the risk of developing breast, ovarian, and certain types of other cancers.
PREVIVE, a new documentary web series to be released in the Fall of 2010, will chronicle Claudia Gilmore's extraordinary journey to defy her destiny by
Site d'informations sur les formes familiales de certains cancers du sein et de l'ovaire. Comment savoir en cas de doute sur cette hérédité ? Que faire ?
I have decided to stop procrastinating and finally finish what I started by setting up this site. So here it is: my first blog post! Let me first introduce
NimaGen is the European distributor of MCLAB products. We also offers prespotted primer plates of the highest quality available for the screening of BRCA1 and BRCA2.
Ambry Genetics is pleased to offer a variety of tests for hereditary breast and ovarian cancer to suit every patient and family. While BRCA1 and BRCA2 are the two most common genes responsible for hereditary breast and ovarian cancer, there are many othe
Ambry Genetics is pleased to offer a variety of tests for hereditary breast and ovarian cancer to suit every patient and family. While BRCA1 and BRCA2 are the two most common genes responsible for hereditary breast and ovarian cancer, there are many othe
NimaGen is the European distributor of MCLAB products. We also offers prespotted primer plates of the highest quality available for the screening of BRCA1 and BRCA2.
No One Fights Alone! Everybody needs somebody sometime. Marenda Hughes Taylor was diagnosed with Triple Negative Breast (BRCA1 positive) at age 39 in...
Medical Ancillary Services, BRCA1 and BRCA2 and BRCA28 Tests (Breast Cancer Ovarian Cancer Testing) │ DNA PharmacoGenetic PGx Testing │ RX Pharmacy Compounding │ Genetic Testing │ Toxicology Drug Testing
The Basser Center has revolutionized BRCA1 and BRCA2 research and patient education. Hear the inspiring words from center leaders Drs. Chi Dang and Susan Domchek on how understanding cancer genetics will transform the future.